Perfusion MRI as a neurosurgical tool for improved targeting in stereotactic tumor biopsies

Stereotactic and Functional Neurosurgery

Volumn 90, Issue 4, 2012, Pages 240-247

  Lefranc, M ^a   Monet, P ^a   Desenclos, C ^a   Peltier, J ^a   Fichten, A ^a   Toussaint, P ^a   Sevestre, H ^a   Deramond, H ^a   Le Gars, D ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Perfusion weighted magnetic resonance imaging; Stereotactic biopsy; Targeting

Indexed keywords

GADOTERIC ACID;

ARTICLE; ASTROCYTOMA; BRAIN BLOOD VOLUME; BRAIN CANCER; BRAIN LYMPHOMA; CANCER GRADING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHO PLANAR IMAGING; GLIOMA; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PERFUSION WEIGHTED IMAGING;

BIOPSY; BRAIN; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; LYMPHOMA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; STEREOTAXIC TECHNIQUES;

EID: 84862228900     PISSN: 10116125     EISSN: 14230372     Source Type: Journal    
DOI: 10.1159/000338092     Document Type: Article

References (27)

1. Kondziolka D, Dade Lunsford L: The role of stereotactic biopsy in the management of gliomas. J Neurooncol 1999; 42: 205-213. (Pubitemid 29322197)
2. Dammers R, Haitsma IK, Schouten JW, Kros JM, Avezaat CJJ, Vincent AJPE: Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir 2008; 150: 23-29.
3. Sawin PD, Hitchon PW, Follett KA, Torner JC: Computed imaging-assisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases. Surg Neurol 1998; 49: 640-649. (Pubitemid 28285426)
4. Jain D, Sharma MC, Sarkar C, Deb P, Gupta D, Mahapatra AK: Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesion. Brain Tumor Pathol 2006; 23: 71-75. (Pubitemid 44607272)
5. Barker FG 2nd, Chang SM, Huhn SL, Davis RL, Gutin PH, McDermott MW, Wilson CB, Prados MD: Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 1997; 80: 936-941. (Pubitemid 27360923)
6. Maia AC Jr, Malheiros SM, da Rocha AJ, et al: Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging. J Neurosurg 2004; 101: 970-976. (Pubitemid 43186449)
7. Chaskis C, Stadnik T, Michotte A, Van Rompaey K, D'Haens J: Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study. Acta Neurochir 2006; 148: 277-285. (Pubitemid 43341026)
8. McGirt MJ, Villavicencio AT, Bulsara KR, Friedman AH: MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg Neurol 2003; 59: 279-283.
9. Chaichana KL, McGirt MJ, Niranjan A, Olivi A, Burger PC, Quinones-Hinojosa A: Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature. Neurol Res 2009: 31: 931-939.
10. Pirotte B, Goldman S, Salzberg S, et al: Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children: experience in 9 cases. Pediatr Neurosurg 2003; 38: 146-155. (Pubitemid 36302462)
11. Pirotte B, Goldman S, David P, et al: Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine. Acta Neurochir Suppl 1997: 68; 133-138.
12. Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F: Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intraaxial brain tumors. Neuroradiology 2006; 48: 150-159. (Pubitemid 43380227)
13. Sugahara T, Korogi Y, Kochi M, et al: Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998; 171: 1479-1486. (Pubitemid 28531609)
14. Russell SM, Elliott R, Forshaw D, Golfinos JG, Nelson PL, Kelly PJ: Glioma vascularity correlates with reduced patient survival and increased malignancy. Surg Neurol 2009; 72: 242-246.
15. Jackson A, Kassner A, Annesley-Williams D, Reid H, Zhu XP, Li KL: Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 2002; 23: 7-14. (Pubitemid 34098254)
16. Schmainda KM, Rand SD, Joseph AM, et al: Characterization of a first-pass gradientecho spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 2004; 25: 1524-1532. (Pubitemid 44383603)
17. Law M, Yang S, Wang H, et al: Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24: 1989-1998. (Pubitemid 37444849)
18. Arvinda HR, Kesavadas C, Sarma PS, et al: Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol 2009; 94: 87-96.
19. Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S: High-grade and lowgrade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005; 60: 493-502. (Pubitemid 40353027)
20. Lev MH, Ozsunar Y, Henson JW, et al: Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendroglimoas. AJNR Am J Neuroradiol 2004; 25: 214-221. (Pubitemid 38235298)
21. Sadeghi N, Salmon I, Tang BN, et al: Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results. J Magn Reson Imaging 2006; 24: 989-994. (Pubitemid 44658234)
22. Prat R, Galeano I, Lucas A, et al: Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas. J Clin Neurosci 2010; 17: 50-53.
23. Okita Y, Kinoshita M, Goto T, et al: (11)Cmethionine uptake correlates with tumor cell density rather than with microvessel density in glioma: a stereotactic image-histology comparison. Neuroimage 2010; 49: 2977-2982.
24. Chi AS, Sorensen AG, Jain RK, Batchelor TT: Angiogenesis as a therapeutic target in malignant gliomas. Oncologist 2009; 14: 621-636.
25. Salmaggi A, Boiardi A, Gelati M, et al: Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 2006; 54: 850-860. (Pubitemid 44671990)
26. Sato A, Sakurada K, Kumabe T, et al: Association of stem cell marker CD133 expression with dissemination of glioblastomas. Neurosurg Rev 2010; 33: 175-183; discussion 183-184.
27. Lehmann P, Monet P, de Marco G, et al: A comparative study of perfusion measurement in brain tumours at 3 Tesla MR: arterial spin labeling versus dynamic susceptibility contrast-enhanced MRI. Eur Neurol 2010; 64: 21-26.